Clinical Trials Logo

Filter by:
NCT ID: NCT05265091 Enrolling by invitation - Clinical trials for Advanced Solid Tumor

A Study of KL590586 in Patients With Advanced Solid Tumors

Start date: June 1, 2021
Phase: Phase 1/Phase 2
Study type: Interventional

An Open, Multi-Center Phase I/II Clinical Study To Evaluate The Safety, Tolerability, Pharmacokinetic Characteristics And Effectiveness Of KL590586 Capsules In Patients With Advanced Solid Tumors Carrying RET Fusion Or Mutant Genes

NCT ID: NCT05258136 Enrolling by invitation - HLH Clinical Trials

Low-dose CD20 Monoclonal Antibody Injection in Preemptive Treatment of PTLD in Patients With EBV-HLH/CAEBV

Start date: June 1, 2021
Phase: N/A
Study type: Interventional

This is a clinical study on the efficacy and safety of low-dose CD20 monoclonal antibody injection in preemptive treatment of EBV positive lymphoproliferative diseases after allo-HSCT in patients with EBV-HLH and CAEBV

NCT ID: NCT05248568 Enrolling by invitation - Clinical trials for Experimental Myasthenia

Effect of Core Training on Physical Fitness and Offensive Skills, 12 Weeks Core Training

Start date: April 1, 2022
Phase: N/A
Study type: Interventional

The 12 week core training plan designed in this study is based on relevant literature and basketball characteristics. The training plan divides the training difficulty into four levels. The experimental group receives core training with different difficulties in 1-3 weeks, 4-6 weeks, 7-9 weeks and 10-12 weeks respectively.

NCT ID: NCT05248360 Enrolling by invitation - Insomnia Clinical Trials

Hydrogen-oxygen Mixed Gas in the Treatment of Insomnia

Start date: October 11, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of hydrogen-oxygen mixed gas inhalation in the treatment of insomnia.

NCT ID: NCT05233293 Enrolling by invitation - Clinical trials for Malignant Biliary Obstruction

Spyglass+RFA Versus Cytobrush+RFA for Extrahepatic Cholangiocarcinoma

Start date: January 1, 2021
Phase: N/A
Study type: Interventional

With the development of endoscopic technology, endoscopic retrograde cholangiopancreatography (ERCP) has been widely used in the diagnosis and treatment of extrahepatic cholangiocarcinoma.In patients with extrahepatic cholangiocarcinoma, cytological brushing performed concurrently with ERCP had a lower pathologically positive rate and increased the times of ERCPs, increased the risk of postoperative complications at the same time.The present study aims to compare the efficacy and safety outcomes of Spyglass+RFA Versus Cytobrush+RFA for Extrahepatic Cholangiocarcinoma.

NCT ID: NCT05214976 Enrolling by invitation - Clinical trials for Advanced Solid Tumors

A Trial of Camrelizumab for Injection in Combination With Famitinib Malate Capsule and Paclitaxel For Injection(Albumin Bound) in Advanced Solid Tumors of Patients

Start date: August 12, 2022
Phase: Phase 2
Study type: Interventional

The study is being conducted to evaluate safety, tolerability and preliminary efficacy of Camrelizumab for Injection in combination with Famitinib malate capsule and Paclitaxel For Injection(Albumin Bound) for advanced solid tumors of patients. To explore the reasonable dosage of dosage regimen of combination therapy for advanced malignant tumors of patients.

NCT ID: NCT05212519 Enrolling by invitation - GDM Clinical Trials

Correlation of Vitamin D Levels in Early Pregnancy With Gestational Diabetes and Pregnancy Outcomes

Start date: January 1, 2022
Phase:
Study type: Observational [Patient Registry]

Explore the specific correlation between different concentration levels of vitamin D in early pregnancy and blood glucose levels at each time node of OGTT, the correlation between different concentrations of vitamin D levels and A1 and A2 diabetes in pregnancy, and the impact on maternal and infant outcomes , And provide a basis for the prevention and treatment of GDM.

NCT ID: NCT05204433 Enrolling by invitation - Clinical trials for Early Diagnosis of Colorectal Cancer and Adenoma

Correlation Between SFRP1 and Colorectal Cancer and Adenoma

Start date: January 5, 2019
Phase:
Study type: Observational

In summary, our study demonstrated the methylation sites of SFRP1 gene promoter in patients with colorectal cancer and adenoma and found SFRP1_16_17_18 CpG site was good performance as a diagnostic marker of colorectal cancer.

NCT ID: NCT05202977 Enrolling by invitation - Clinical trials for Transcatheter Aortic Valve Replacement

Safety and Efficacy of SinocrownTM Transcatheter Aortic Valve Replacement System

Start date: April 6, 2021
Phase: N/A
Study type: Interventional

This study was designed to preliminary verify the safety and of efficacy of SinocrownTM Transcatheter Aortic Valve Replacement System With accessories in patients with symptomatic, calcified and severe aortic stenosis using objective performance criteria

NCT ID: NCT05198817 Enrolling by invitation - Clinical trials for Advanced Malignant Tumors

A Trial of SHR-2002 Injection or Combined With Other Anti-cancer Medication in Advanced Malignant Tumors of Patients

Start date: February 22, 2022
Phase: Phase 1
Study type: Interventional

The study is being conducted to evaluate safety, tolerability, pharmacokinetics and preliminary efficacy of SHR-2002 injection monotherapy and in combination with other anti-cancer therapy for advanced malignant tumors of patients. To explore the reasonable dosage of SHR-2002 injection monotherapy and dosage regimen of combination therapy for advanced malignant tumors of patients.